<DOC>
	<DOC>NCT00934947</DOC>
	<brief_summary>The purpose of this study is to investigate the ability of propranolol to decrease pain and improve recovery in burn patients with a common genotype.</brief_summary>
	<brief_title>Burn Healing and Analgesia With Propranolol</brief_title>
	<detailed_description />
	<mesh_term>Burns</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Thermal burn Greater than or equal to 18 years of age Less than 60 years of age Able to speak and read English Intubated Clinically unstable Other substantial comorbid injury (e.g. long bone fracture) Heart block greater than first degree (EKG) History of coronary artery disease History of congestive heart failure Asthma (within past 10 years, induced by a betablocker, or receiving current treatment) Pregnant Prisoner Psychotic, suicidal, or homicidal Diabetic Hepatic failure (acute or chronic) Renal failure (acute or chronic) History of hyperthyroidism unless taking synthroid or other thyroid hormone replacement Exceeds daily acceptable chronic opioid use prior to burn Interacting medication Received propranolol within the last 6 months Multiple severe allergic reactions On daily methylphenidate or similar stimulant medication Unwilling to use medically acceptable birth control (if childbearing potential) Breastfeeding Severe peripheral vascular disease or vasospastic disorder Bradycardia that in the opinion of the investigator would constitute too great a risk when considered in the context of the patient's medical comorbidities and health history Other criteria that in investigator's opinion makes participant poor candidate for the trial Cancer (except basal cell cancer)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Burns</keyword>
	<keyword>Pain</keyword>
</DOC>